ロード中...
An Imatinib–non‐responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization
Leu387Trp mutation, aroused in an imatinib‐non‐responsive CML patient, was selected by imatinib treatment along with other unknown factors responsible for resistance, and then it was overcome by bosutinib. These results will be useful for treating patients with this rare mutation and will advise aga...
保存先:
| 出版年: | Clin Case Rep |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6982521/ https://ncbi.nlm.nih.gov/pubmed/31998490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2531 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|